Tiziana life sciences announces presentations on intranasal foralumab at the “preserving the brain” scientific conference and exhibit at prada rong zhai in shanghai

New york, april 10, 2023 (globe newswire) -- tiziana life sciences ltd. (nasdaq: tlsa) (“tiziana” or the “company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that poster presentations on intranasal foralumab are being presented at the “preserving the brain” scientific conference and exhibit held at the fondazione prada in rong zhai in shanghai.
TLSA Ratings Summary
TLSA Quant Ranking